This article is more than 5 years old. Information may no longer be current.

IOL allows spectacle independence

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — Nearly 100% of patients in an apodized diffractive IOL study were spectacle free 1 year after surgery, Robert A. Kaufer, MD, said.

He spoke here at the American Society of Cataract and Refractive Surgery about a year-long study he conducted in Argentina on a total of 51 patients implanted with the ReSTOR IOL (Alcon).

Dr. Kaufer said 99% of patients had spectacle freedom, while 100% would have the same surgery again. They would also recommend the surgery to their best friend, he said. The majority of patients reported no or mild night vision, halo or glare. The side effects were deemed “tolerable” by the patients and were not intrusive enough to forego having the surgery, they said.

The mean uncorrected distance vision was 20/20, and mean uncorrected near visual acuity was 20/16. Mean uncorrected intermediate VA was 20/25, Dr. Kaufer said.